Parallel synthesis and antileishmanial activity of ether-linked phospholipids

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 16, 2008, Pages 4658-4660

  Coghi, Paolo ^a   Vaiana, Nadia ^a   Pezzano, Maria G ^a   Rizzi, Luca ^a   Kaiser, Marcel ^b   Brun, Reto ^b   Romeo, Sergio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Antiprotozoal activity; Edelfosine; Ether linked phospholipids; Leishmania donovani; Parallel synthesis

Indexed keywords

ANTILEISHMANIAL AGENT; EDELFOSINE; ETHER PHOSPHOLIPID; GLYCEROL; MILTEFOSINE; OCTADECANOL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONFOCAL MICROSCOPY; DRUG ACTIVITY; DRUG MECHANISM; DRUG SYNTHESIS; FLUORESCENCE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID PHASE SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIPROTOZOAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY; DRUG DESIGN; ETHERS; GLYCEROL; HUMANS; INHIBITORY CONCENTRATION 50; LEISHMANIA DONOVANI; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, CHEMICAL; PHOSPHOLIPIDS; POLYMERS;

LEISHMANIA DONOVANI;

EID: 48649098491     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.07.022     Document Type: Article

References (24)

1. Stuart K., Brun R., Croft S., Fairlamb A., Gurtler Ricardo E., McKerrow J., Reed S., and Tarleton R. J. Clin. Invest. 118 (2008) 1301
2. Mishra J., Saxena A., and Singh S. Curr. Med. Chem. 14 (2007) 1153
3. de Castro S.L., Santa-Rita R.M., Urbina J.A., and Croft S.L. Mini-Rev. Med. Chem. 4 (2004) 141
4. Mollinedo F. Expert Opin. Ther. Pat. 17 (2007) 385
5. Croft S.L., Snowdon D., and Yardley V. J. Antimicrob. Chemother. 38 (1996) 1041
6. Mollinedo F., Fernandez-Luna J.L., Gajate C., Martin-Martin B., Benito A., Martinez-Dalmau R., and Modotell M. Cancer Res. 57 (1997) 1320
7. Croft S.L., Seifert K., and Duchene M. Mol. Biochem. Parasitol. 126 (2003) 165
8. Croft S.L., Barrett M.P., and Urbina J.A. Trends Parasitol. 21 (2005) 508
9. Herwaldt B.L. N. Eng. J. Med. 341 (1999) 1840
10. Sindermann H., Engel K.R., Fischer C., and Bommer W. Clin. Infect. Dis. 39 (2004) 1520
11. Brachwitz H., and Vollgraf C. Pharmacol. Ther. 66 (1995) 39
12. Wieder T., Reutter W., Orfanos C.E., and Geilen C.C. Prog. Lipid Res. 38 (1999) 249
13. Saugar J.M., Delgado J., Hornillos V., Luque-Ortega J.R., Amat-Guerri F., Acuna A.U., and Rivas L. J. Med. Chem. 50 (2007) 5994
14. Calogeropoulou T., Angelou P., Detsi A., Fragiadaki I., and Scoulica E. J. Med. Chem. 51 (2008) 897
15. Kapou A., Benetis N.P., Avlonitis N., Calogeropoulou T., Koufaki M., Scoulica E., Nikolaropoulos S.S., and Mavromoustakos T. Bioorg. Med. Chem. 15 (2007) 1252
16. Avlonitis N., Lekka E., Detsi A., Koufaki M., Calogeropoulou T., Scoulica E., Siapi E., Kyrikou I., Mavromoustakos T., Tsotinis A., Grdadolnik S.G., and Makriyannis A. J. Med. Chem. 46 (2003) 755
17. Houlihan W.J., Lohmeyer M., Workman P., and Cheon S.H. Med. Res. Rev. 15 (1995) 157
18. Crowley J.I., and Rapoport H. Acc. Chem. Res. 9 (1976) 135
19. Thompson L.A., and Ellman J.A. Tetrahedron Lett. 35 (1994) 9333
20. 2 (3 times), and finally dried at 60 °C under reduced pressure.
21. 2 (3 times).
22. Rampy M.A., Pinchuk A.N., Weichert J.P., Skinner R.W.S., Fisher S.J., Wahl R.L., Gross M.D., and Counsell R.E. J. Med. Chem. 38 (1995) 3156
23. +]: m/z 663.3.
24. Tasdemir D., Kaiser M., Brun R., Yardley V., Schmidt T.J., Tosun F., and Ruedi P. Antimicrob. Agents Chemother. 50 (2006) 1352